載入...
A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321
INTRODUCTION: Despite the advances in radiation techniques and chemotherapy, survival with current platinum-based chemotherapy and concomitant thoracic radiation remains dismal. Bortezomib, a proteasome inhibitor, modulates apoptosis and cell cycle through disruption of protein degradation. The comb...
Na minha lista:
發表在: | J Thorac Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4320011/ https://ncbi.nlm.nih.gov/pubmed/25247339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000383 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|